跳至主要内容
临床试验/JPRN-UMIN000030448
JPRN-UMIN000030448尚未招募未知

ow-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4 - ESWT-CKD

Osaka University Graduate School of Medicine0 个研究点目标入组 66 人开始时间: 2019年4月1日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with a local skin infection at the contact site with the applicator Patients with bleeding tendency Patients with urolithiasis or kidney stones Patients with hydronephrosis Patients with active pyelonephritis Patients with cancer Patients treated with steroids or immunosuppressants Patients who is expected to introduce dialysis within 12 weeks Polycystic kidney disease patients Patients with renal morphological abnormality Patients who received kidney transplantation Dialysis patients (HD, PD) Patients whose renal blood flow cannot be evaluated Objects considered by the attending physician as inappropriate

研究者

相似试验

ow-power extracorporeal shock wave therapy for... | 临床试验